Showing results (211-220 of 513) with videos related to

Sort By:
Pageof 52
Leukemia|July 31, 2004
Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosisC Blin-Wakkach, A Wakkach, P M Sexton, et al.
Molecular Pharmacology|February 5, 2005
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexesDebbie L Hay, George Christopoulos, Arthur Christopoulos, et al.
Endocrinology|April 4, 2017
Coexpressed Class B G Protein-Coupled Secretin and GLP-1 Receptors Self- and Cross-Associate: Impact on Pancreatic IsletsKaleeckal G Harikumar, Shannen Lau, Patrick M Sexton, et al.
Biochemical Pharmacology|April 2, 2017
Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1Marlies V Hager, Lachlan Clydesdale, Samuel H Gellman, et al.
Archives of Dermatology|March 1, 1991
Cytomegalovirus diaper dermatitisD M Thiboutot, A Beckford, C R Mart, et al.
Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs as drug targetsPatrick M Sexton, David R Poyner, John Simms, et al.
Biochemical Society Transactions|April 13, 2016
The complexity of signalling mediated by the glucagon-like peptide-1 receptorMadeleine M Fletcher, Michelle L Halls, Arthur Christopoulos, et al.
Molecular Pharmacology|December 1, 2012
Allosteric modulation of a chemogenetically modified G protein-coupled receptorAlaa Abdul-Ridha, J Robert Lane, Patrick M Sexton, et al.
Biochemistry|November 6, 2009
Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptorKaleeckal G Harikumar, John Simms, George Christopoulos, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environmentN Tilakaratne, G Christopoulos, E T Zumpe, et al.
Pageof 52